Trade

with

Chembio Diagnostics Inc
(NASDAQ: CEMI)
AdChoices
3.83
-0.21
-5.20%
After Hours :
-
-
-

Open

3.96

Previous Close

4.04

Volume (Avg)

15.91k (49.51k)

Day's Range

3.82-3.98

52Wk Range

2.83-4.66

Market Cap.

36.81M

Dividend Rate ( Yield )

-

Beta

-0.12

Shares Outstanding

9.61M

P/E Ratio (EPS)

434.78 (0.01)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Diagnostics & Research
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 29.55M

    • Net Income

    • 530.82k

    • Market Cap.

    • 36.81M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 0.27

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • -0.12

    • Forward P/E

    • -80.65

    • Price/Sales

    • 1.27

    • Price/Book Value

    • 1.92

    • Price/Cash flow

    • -34.72

      • EBITDA

      • 1.63M

      • Return on Capital %

      • 0.35

      • Return on Equity %

      • 0.42

      • Return on Assets %

      • 0.35

      • Book Value/Share

      • 2.11

      • Shares Outstanding

      • 9.61M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Buy
        • 1 Year Price Target

        • 5.50

        • Credit Rating

        • -

        • Analysts

        • 2

        • EPS Estimate

        • -0.06

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 37.60

          • 21.91

          • Net Income

            YTD/YTD (last year)

          • -43.60

          • -5.55

          • Net Income

            Q/Q (last year)

          • -

          • 0.44

          • Sales (Revenue)

            5-Year Annual Average

          • 21.74

          • 47.82

          • Net Income

            5-Year Annual Average

          • -

          • 4.98

          • Dividends

            5-Year Annual Average

          • -

          • 5.31

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 40.96

            • 42.70

            • Pre-Tax Margin

            • 0.92

            • 11.63

            • Net Profit Margin

            • 0.27

            • 9.55

            • Average Gross Margin

              5-Year Annual Average

            • 44.60

            • 43.76

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 6.40

            • 11.34

            • Average Net Profit Margin

              5-Year Annual Average

            • 11.00

            • 52.13B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.62

              • Current Ratio

              • 4.61

              • 1.23

              • Quick Ratio

              • 3.23

              • 0.76

              • Interest Coverage

              • -

              • 5.98

              • Leverage Ratio

              • 1.19

              • 2.16

              • Book Value/Share

              • 2.11

              • 14.94

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 434.78

                • 33.44

                • P/E Ratio 5-Year High

                • 665.14

                • 325.07

                • P/E Ratio 5-Year Low

                • 145.87

                • 154.73

                • Price/Sales Ratio

                • 1.20

                • 2.32

                • Price/Book Value

                • 1.82

                • 3.05

                • Price/Cash Flow Ratio

                • -34.72

                • 19.05

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • 0.42

                        (29.10)

                      • 9.34

                        (9.80)

                      • Return on Assets %

                        (5-Year Average)

                      • 0.35

                        (19.30)

                      • 4.63

                        (5.44)

                      • Return on Capital %

                        (5-Year Average)

                      • 0.42

                        (25.30)

                      • 5.73

                        (6.77)

                      • Income/Employee

                      • 407.59

                      • 17.17k

                      • Inventory Turnover

                      • 4.57

                      • 5.07

                      • Asset Turnover

                      • 1.29

                      • 0.48

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      1.00M
                      Operating Margin
                      3.40
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -34.72
                      Ownership

                      Institutional Ownership

                      17.63%

                      Top 10 Institutions

                      17.37%

                      Mutual Fund Ownership

                      1.56%

                      Float

                      97.50%

                      5% / Insider Ownership

                      16.07%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Vanguard Total Stock Mkt Idx

                      •  

                        120,789

                      • 0.00

                      • 1.26

                      • Vanguard Extended Market Index Fund

                      •  

                        19,255

                      • 0.00

                      • 0.20

                      • iShares Micro-Cap

                      •  

                        4,223

                      • 1.30

                      • 0.05

                      • Fidelity Spartan® Extended Mkt Indx Fd

                      •  

                        4,082

                      • 0.00

                      • 0.04

                      • AXA/Lord Abbett Micro Cap Portfolio

                      •  

                        1,416

                      • 0.00

                      • 0.01

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Wellington Management Company, LLP

                      •  

                        958,480

                      • +16.85%

                      • 9.97

                      • Stanley-Laman Group Ltd.

                      •  

                        308,919

                      • -3.06%

                      • 3.22

                      • Vanguard Group, Inc.

                      •  

                        140,044

                      • 0.00%

                      • 1.46

                      • Municipal Employees' Retirement System of Michigan

                      •  

                        94,900

                      • 0.00%

                      • 0.99

                      • Dafna Capital Management LLC

                      •  

                        55,202

                      • 0.00%

                      • 0.57

                      • Phocas Financial Corp

                      •  

                        21,200

                      • 0.00%

                      • 0.22

                      • Creative Planning, Inc.

                      •  

                        11,130

                      • 0.00%

                      • 0.11

                      • Franklin Street Advisors Inc.

                      •  

                        10,000

                      • -9.37%

                      • 0.10

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Diagnostics & Research

                      Type

                      Speculative Growth

                      Style

                      Small Growth

                      Chembio Diagnostics, Inc. was formed in 1985. On May 5, 2004, the Company completed a merger with Chembio Diagnostic Systems Inc. through which Chembio Diagnostics Systems Inc. became the Company’s wholly-owned subsidiary, and throug...moreh which the management and business of Chembio Diagnostic Systems Inc. became its management and business. The Company with its subsidiaries develops, manufacture and market diagnostic tests that detect infectious diseases. The Company’s main products presently commercially available are four rapid tests for the detection of HIV antibodies in whole blood, serum and plasma samples, all of which Employ lateral flow technology, and two of which were approved by the FDA in 2006. The Company’s products are sold to medical laboratories and hospitals, governmental and public he...morealth entities, non-governmental organizations, medical professionals and retail establishments both domestically and internationally. The Company’s products are sold under its STAT PAK, SURE CHECK or DPP registered trademarks. The Company’s HIV tests are qualitative (reactive/non-reactive) tests. Many of its competitors are substantially larger and have greater financial, research, manufacturing and marketing resources. The manufacturing and marketing of the Company’s existing and proposed diagnostic products are regulated by the United States Food and Drug Administration (‘FDA’), United States Department of Agriculture (‘USDA’), certain state and local agencies, and/or comparable regulatory bodies in other countries.lessless

                      Key People

                      Mr. John J. Sperzel, III

                      CEO/Director/President

                      Richard J. Larkin

                      CFO/Chief Accounting Officer

                      Tom Ippolito

                      Vice President, Divisional

                      Katherine L. Davis

                      Director

                      Dr. Gary Meller

                      Director

                      • Chembio Diagnostics Inc

                      • 3661 Horseblock Road

                      • Medford, NY 11763

                      • USA.Map

                      • Phone: +1 631 924-1135

                      • Fax: +1 631 924-2065

                      • chembio.com

                      Incorporated

                      1985

                      Employees

                      206

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: